GH Research PLC (NASDAQ: GHRS), a promising player in the biotechnology sector, has caught the attention of investors with its remarkable potential upside of 121.25%. Based..
CareDx, Inc. (NASDAQ: CDNA), a key player in the healthcare sector with a focus on diagnostics and research, has been gaining traction among investors due to..
Kura Oncology, Inc. (NASDAQ: KURA) has captured the attention of investors in the healthcare sector, with a market cap of $793.54 million. As a clinical-stage biopharmaceutical..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a promising name in the biotechnology sector, has caught the attention of investors with its cutting-edge approach to precision medicine. Based..
CeriBell, Inc. (CBLL), a dynamic player in the healthcare sector specializing in medical devices, is capturing investor attention with its cutting-edge approach to acute care diagnostics...
Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company based in Lexington, Massachusetts, is capturing the attention of investors with its promising pipeline and significant potential..
Bicara Therapeutics Inc. (NASDAQ: BCAX) offers a compelling narrative in the biotechnology sector, commanding attention with its innovative approach to solid tumor treatment and a promising..
Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at a fascinating juncture within the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is emerging as an intriguing opportunity in the biotech sector, capturing investor attention with its promising pipeline and significant upside potential...
Enliven Therapeutics, Inc. (NASDAQ: ELVN), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of cancer treatment drugs...
Anavex Life Sciences Corp. (NASDAQ: AVXL) presents an intriguing opportunity for investors in the biotech sector, particularly given its remarkable potential upside of 547.06%. This New..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, has captured the attention of investors with its focus on innovative therapies for central nervous system..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing the attention of savvy investors, thanks to a promising potential upside of 136.84% based on the average analyst target..
Nutex Health Inc. (NASDAQ: NUTX) has emerged as a compelling player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector with its focus on pain management solutions, a vital niche within the drug manufacturing industry...
Investors looking to tap into the burgeoning healthcare sector might want to take a closer look at Neuropace, Inc. (NASDAQ: NPCE), a trailblazer in the medical..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is attracting significant investor attention due to its promising pipeline aimed at treating severe autoimmune diseases. With..
Arbutus Biopharma Corporation (NASDAQ: ABUS) stands as a significant player in the biotechnology sector, capturing investor attention with its focus on developing novel therapeutics for infectious..
